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Endoplasmic reticulum stress inhibition protects
steatotic and non-steatotic livers in partial
hepatectomy under ischemia–reperfusion
I Ben Mosbah1, I Alfany-Ferna´ndez2, C Martel3, MA Zaouali1, M Bintanel-Morcillo2, A Rimola4,5, J Rode´s4,5, C Brenner*,3,6,
J Rosello´-Catafau1,2,5 and C Peralta2,5,6
During partial hepatectomy, ischemia–reperfusion (I/R) is commonly applied in clinical practice to reduce blood flow. Steatotic
livers show impaired regenerative response and reduced tolerance to hepatic injury. We examined the effects of
tauroursodeoxycholic acid (TUDCA) and 4-phenyl butyric acid (PBA) in steatotic and non-steatotic livers during partial
hepatectomy under I/R (PHþ I/R). Their effects on the induction of unfolded protein response (UPR) and endoplasmic reticulum
(ER) stress were also evaluated. We report that PBA, and especially TUDCA, reduced inflammation, apoptosis and necrosis,
and improved liver regeneration in both liver types. Both compounds, especially TUDCA, protected both liver types against
ER damage, as they reduced the activation of two of the three pathways of UPR (namely inositol-requiring enzyme and PKR-like
ER kinase) and their target molecules caspase 12, c-Jun N-terminal kinase and C/EBP homologous protein-10. Only TUDCA,
possibly mediated by extracellular signal-regulated kinase upregulation, inactivated glycogen synthase kinase-3b. This is turn,
inactivated mitochondrial voltage-dependent anion channel, reduced cytochrome c release from the mitochondria and caspase
9 activation and protected both liver types against mitochondrial damage. These findings indicate that chemical chaperones,
especially TUDCA, could protect steatotic and non-steatotic livers against injury and regeneration failure after PHþ I/R.
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Therapeutic strategies to inhibit cell death in liver injury have
the potential to provide a powerful tool for the treatment of liver
disease characterized by cell loss, such as ischemia–
reperfusion (I/R), alcoholic or nonalcoholic fatty liver disease.
Indeed, with an improved understanding of the molecular
pathways and the pathophysiological role of apoptosis, new
drugs aimed at therapeutically modulating cell death are now
available for clinical trials and/or as new therapeutic options
for the treatment of several human diseases. In clinical
situations, partial hepatectomy is usually performed under I/R
to control bleeding during parenchymal dissection. Hepatic
steatosis, a major risk factor for liver surgery, has been
associated with increased complications and postoperative
mortality after major liver resection. Steatotic livers show
impaired regenerative response and reduced tolerance to
hepatic injury compared with non-steatotic livers.1 A further
increase in the prevalence of steatosis in hepatic surgery is to
be expected. These observations highlight the need to
develop protective strategies for steatotic livers in partial
hepatectomy under I/R (PHþ I/R). The endoplasmic reticu-
lum (ER) regulates protein synthesis, protein folding and
trafficking and intracellular calcium levels. ER stress has been
associated with the development of several human chronic
diseases.2 In response to ER stress, a signal transduction
cascade termed ‘the unfolded protein response (UPR)3,4 is
induced. The UPR has three branches: inositol-requiring
enzyme 1 (IRE1), PKR-like ER kinase (PERK) and activating
transcription factor (ATF6). These proteins are normally held
in inactive states in ER membranes by binding to intra-ER
chaperones, particularly the 78-kDa glucose-regulated/bind-
ing immunoglobulin protein (GRP78). In response to stimuli
that divert ER chaperones to misfolded proteins, IRE1, PERK
and ATF6 initiate signal transduction processes to promote
the expression of genes required for folding of newly
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synthesized proteins and for degradation of unfolded proteins
to reestablish homeostasis and normal ER function. However,
when injury is excessive, these same ER stress signal
transduction pathways can also induce cell death.3,4
The first of the three branches of the UPR includes IRE1a
which, once activated, induces the unconventional splicing of
the mRNA encoding X-box-binding protein 1 (XBP-1). The
cytosolic domain of activated IRE1a binds the tumor necrosis
factor (TNF)-associated factor 2 (TRAF2), and triggers the
activation of the c-Jun N-terminal kinase (JNK), MAPK p38
and caspase 12.3,5 The second branch is mediated by PERK,
which phosphorylates Ser21 of the a-subunit of eukaryotic
translation initiation factor 2 (eIF2a). eIF2a phosphorylation
induces translation of a basic-region leucine zipper (bZIP)
transcription factor ATF4 and subsequent expression of ATF4
target genes, C/EBP homologous protein-10 (CHOP).3,6 The
third branch is mediated by the bZIP transcription factor ATF6,
which is activated by regulated intramembrane proteolysis.3,7
ER stress and mitochondrial damage are closely
linked.8,9 ER stress induces glycogen synthase kinase-3b
(GSK3b),10,11 which phosphorylates voltage-dependent an-
ion channel (VDAC), the most abundant protein in the outer
membrane of the mitochondria, and this in turn increases cell
death.12–14 The suppression of GSK3b activity is crucial for
VDAC regulation.12,14 Several reports in cardiomyocytes and
neuroblastoma cells have indicated that protein kinases such
as extracellular signal-regulated kinase (ERK) are responsi-
ble for direct inactivation of GSK3b.12,14,15
Chemical or pharmaceutical chaperones, such as 4-phenyl
butyric acid (PBA) and endogenous bile acids, and deriva-
tives, such as tauroursodeoxycholic acid (TUDCA), modulate
ER stress.16,17 Under conditions of I/R without hepatectomy,
PBA protected non-steatotic livers against hepatic injury by
inhibition of ER stress-mediated apoptosis and inflamma-
tion.17 TUDCA protected from hepatocellular necrosis under
cold ischemia conditions.18 In addition, TUDCA increased
hepatocellular proliferation in bile duct ligation-vagotomized
rats and patients affected by chronic hepatitis.19,20 Given the
ability of PBA and TUDCA to regulate inflammatory response,
cell death and cell proliferation in various diseases,17–20 we
examined the effects of these ER stress inhibitors (PBA and
TUDCA) on hepatic injury and liver regeneration in steatotic
and non-steatotic livers in PHþ I/R. Under these conditions,
we also analyzed the effect of PBA and TUDCA on the
induction of UPR in both liver types. Our findings could
contribute to the development of new pharmacological
strategies based on modulating ER stress and cell death to
protect steatotic and non-steatotic livers from I/R injury and to
improve liver regeneration in PHþ I/R.
Results
Effect of ER stress inhibitors on hepatic injury and
regeneration in steatotic and non-steatotic livers in
PHþ I/R
Necrosis and apoptosis. Transaminase levels and damage
score were higher in PHþ I/R in steatotic livers than in non-
steatotic livers, indicating the vulnerability of this type of liver
to surgery (Figure 1a). In the PBA and TUDCA groups of
both liver types, and especially the TUDCA group, plasma
transaminase levels were lower than in the PHþ I/R group
(Figure 1a). The histological results (Figure 1a) followed a
pattern similar to that described for transaminases.
Inflammation response was also evaluated by measuring
TNFa, interleukin (IL)1b, neutrophil accumulation and oxida-
tive stress.21,22 PHþ I/R increased TNFa and IL1b levels
(Figure 1b), as well as neutrophil accumulation and oxidative
stress (evidenced by the results of myeloperoxidase (MPO)
and ROS, respectively) (Figure 1c) in both liver types
compared with the sham group. In steatotic livers, all
inflammation mediators tested were increased compared with
non-steatotic livers. In the PBA and TUDCA groups,
especially the latter, TNFa, IL1b, MPO and malondialdehyde
(MDA) levels were lower in both liver types than in the
PHþ I/R group (Figure 1b and c).
Apoptosis was evaluated by TUNEL and caspase 3
activation, a downstream event in the apoptotic cascade.23
PHþ I/R increased the percentage of TUNEL-positive cells
and caspase 3 activation (Figure 2a) in both liver types when
compared with the sham group. The results of TUNEL and
caspase 3 indicated lower apoptosis in PHþ I/R of steatotic
livers than of non-steatotic livers, which is in accordance with
previous studies indicating that apoptosis is predominant in
non-steatotic livers.23 In the PBA and TUDCA groups, and
particularly in the TUDCA group, decreased cell TUNEL
staining and reduced caspase 3 activity were observed in both
liver types when compared with the PHþ I/R group
(Figure 2a). Regarding the ER apoptotic cascade, PHþ I/R
increased caspase 12 activity in both liver types when
compared with the sham group (Figure 2b). Caspase 12 is
essential for ER stress-induced apoptosis.5 In steatotic livers
of the PHþ I/R group, this mediator of ER apoptosis was lower
than in non-steatotic livers. In the PBA and TUDCA groups,
and particularly in the latter, caspase 12 levels were lower
than in the PHþ I/R group (Figure 2b). Cytochrome c release
after mitochondrial damage induces caspase 9 release, which
mediates apoptotic signals.6 Regarding the mitochondrial
apoptotic cascade, PHþ I/R increased cytosolic cytochrome
c and caspase 9 activities in both liver types when compared
with the sham group. In steatotic livers of the PHþ I/R group,
all mediators of mitochondrial apoptosis tested were lower
than in non-steatotic livers (Figure 2b). In the PBA group of
both liver types, cytosolic cytochrome c and caspase 9 levels
were similar to those of the PHþ I/R group. However, in the
TUDCA group, reduced cytosolic cytochrome c and cleaved
caspase 9 levels were observed in both liver types when
compared with the PHþ I/R group (Figure 2b).
ER and mitochondrial damage were evaluated in both liver
types. The results of damage score indicated that the ER and
mitochondria are more damaged in steatotic livers of the
PHþ I/R group than in non-steatotic livers. In the PBA and
TUDCA groups, and particularly in the latter, ER damage was
lower than in the PHþ I/R group (Figure 3a). Only TUDCA
protected against mitochondrial damage in both liver types.
Thus, damage score levels in the mitochondria of the PBA
group were similar to those of the PHþ I/R group. However,
reduced damage score levels were observed in the mitochon-
dria of the TUDCA group when compared with the PHþ I/R
group (Figure 3a). Figure 3b shows the ultrastructural
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alterations of the ER and mitochondria observed in steatotic
livers of all groups. The ultrastructural alteration of ER
observed in steatotic livers of the PHþ I/R group were the
following: ER was disordered; the membranes on either side
of the vesicles show frequent in-pocketing and out-pocketing,
giving profiles resembling a series of interconnecting
bulbs. Increased numbers of lysosomal-related structures
and cytoplasmic vesiculation and vacuolization were also
observed. The PBA and TUDCA groups showed respectively,
minimal and no structural alterations of ER. The ultrastructural
alterations of the mitochondria observed in steatotic livers of
the PHþ I/R group were as follows: extensive mitochondrial
cristae breakdown, mitochondrial condensation with heavy
electron-dense matrix, highly swollen mitochondria that had
lost all their cristae and appeared as large bags containing fine
electron-dense granules and rupture of the mitochondrial
membrane. In the PBA group, the ultrastructural alterations of
the mitochondria were similar to those of the PHþ I/R group.
However, in the TUDCA group, the mitochondrial structure
was normal in steatotic livers. Electron microscopic analysis in
steatotic livers showed more disruption of the plasma
membrane and organelles with a relative preservation of
nuclear morphology when compared with the nucleus of non-
steatotic livers (electronic microscopic images not shown).
This is in accordance with previous studies indicating that
apoptosis and necrosis is predominant in non-steatotic livers
and steatotic livers, respectively.23
Liver regeneration. To determine the effect of PBA and
TUDCA on liver regeneration, we measured PCNA and the
growth factors, hepatocyte growth factor (HGF) and
transforming growth factor (TGF)b. Both HGF and TGFb
promote and inhibit liver regeneration, respectively.24,25
The rate of proliferation (assessed by PCNA) was lower in
PHþ I/R of steatotic livers than of non-steatotic livers
(Figure 4), indicating the failure of steatotic livers to
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Figure 1 Hepatic damage and inflammatory response. (a) Transaminases and damage score, (b) TNFa and IL1b levels and (c) MPO and MDA levels were measured in
both liver types. *Po0.05 versus sham; þPo0.05 versus PHþ I/R
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regenerate. This was in accordance with the growth factor
levels as lower HGF and higher TGFb levels were observed
in steatotic livers of the PHþ I/R group than in non-steatotic
livers (Figure 4). In the PBA and TUDCA groups, and
particularly in the TUDCA group, higher PCNA and HGF
levels and lower TGFb levels were observed in both liver
types when compared with the PHþ I/R group (Figure 4).
Total hepatic TGFb levels were similar in all groups (data not
shown).
Effect of ER stress inhibitors on the induction of UPR in
steatotic and non-steatotic livers in PHþ I/R
GRP78. To examine the effect of PHþ I/R on the induction
of UPR in steatotic and non-steatotic livers, GRP78 levels, a
classical ER stress marker, were determined. PHþ I/R
increased GRP78 mRNA and protein levels in both liver
types, whereas GRP78 levels in steatotic livers were lower
than in non-steatotic livers (Po0.05) (Figure 5a), indicating
that steatosis is related to ER stress modulation. In the PBA
and TUDCA groups, and particularly in the TUDCA group,
GRP78 levels were lower in both liver types than in the
PHþ I/R group. As the induction of GRP78 is indicative of the
activation of the UPR, we examined which of the three
branches of the UPR (ATF6, IRE and PERK) are activated in
both liver types.
The ATF6 pathway. During ER stress, ATF6 is converted
from a 90-kDa protein (p90ATF6a or p90ATF6b) to a 50-kDa
protein (p50ATF6a or p50ATF6b).6 Thus, we analyzed the
effect of PHþ I/R on hepatic p50ATF6a and p50ATF6b
protein expression in steatotic and non-steatotic livers.
PHþ I/R increased p50ATF6a and p50ATF6b levels in both
liver types compared with the sham group (Figure 5b).
However, the PBA and TUDCA groups of both liver types
resulted in p50ATF6a and p50ATF6b levels similar to those
of the PHþ I/R group.
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Figure 2 Apoptosis cell death, endoplasmic reticulum and mitochondrial apoptotic cascade. (a) Percentage of TUNEL-positive hepatocytes, the expression of caspase 3
activity and cleaved caspase 3 in both liver types. (b) Expression of caspase 12, cytochrome c and cleaved caspase 9 in both liver types. Representative western blots of
cleaved caspase 3, caspase 12, cytochrome c and cleaved caspase 9 at the top and densitometric analysis at the bottom. *Po0.05 versus sham; þPo0.05 versus PHþ I/R
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The IRE1 pathway. IRE1 activation induced by ER stress,
was measured by monitoring sXBP-1 and TRAF2. IRE1 cuts
the unspliced XBP1 (XBP1(U)) mRNA into spliced XBP1
(XBP1(S)) mRNA, which encodes the transcriptionally active
XBP-1(S) protein. Thus, we examined hepatic XBP-1(S)
protein expression.3 PHþ I/R increased XBP-1(S) protein
levels in steatotic and non-steatotic livers when compared
with the sham group (Figure 6a). This confirms that PHþ I/R
activates the IRE1/XBP-1 pathway in both liver types.
XBP-1(S) levels were lower in steatotic livers. In the
TUDCA and PBA groups, and particularly in the TUDCA
group, reduced protein XBP-1(S) levels were observed in
both liver types compared with the PHþ I/R group. PHþ I/R
increased TRAF2 protein levels in both liver types, especially
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in non-steatotic livers (Figure 6a). In the TUDCA and PBA
groups, and particularly in the TUDCA group, reduced
TRAF2 levels were observed in both liver types when
compared with the PHþ I/R group. TRAF2 activates JNK,
caspase 12 and p38.3,5 Similar to the results of TRAF2
(Figure 6a), PHþ I/R increased phosphorylated JNK (pJNK)
protein expression in both liver types, with lower pJNK levels
in steatotic livers (Figure 6b). In the TUDCA and PBA groups,
and particularly in the TUDCA group, reduced pJNK levels
were observed in both liver types compared with the PHþ I/R
group. The results of caspase 12 (Figure 2b) followed a
similar pattern to that described for TRAF2. However, this
was not the case of phosphorylated p38 (pP38). Thus, in the
TUDCA and PBA groups, and particularly in the TUDCA
group, pP38 levels increased in both livers when compared
with the PHþ I/R group (Figure 6b). Total JNK and p38 levels
were similar in all groups.
The PERK pathway. PERK phosphorylates eIF2a in
response to ER stress. The phosphorylation of eIF2a
induces a translation of ATF4 mRNA into the corres-
ponding protein, which in turn induces different genes,
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including CHOP.3,6 Thus, we assessed hepatic expression
levels of phospho-PERK (pPERK), phospho-eIF2a
(peIF2a), ATF4 and CHOP by western blotting.
PHþ I/R induced PERK and eIF2a phosphorylation
(Figure 7a), ATF4 accumulation and increased CHOP
protein levels (Figure 7b) in both liver types compared with
the sham group. Indeed, PERK and eIF2a phosphorylation
and ATF4 and CHOP protein expression levels in the
untreated group were lower in steatotic livers than in non-
steatotic livers (Po0.05), confirming the impact of steatosis
on ER stress. In the TUDCA and PBA groups, and
particularly in the TUDCA group, reduced PERK activation
and downregulation of the levels of peIF2a, ATF4 and CHOP
were observed in both liver types when compared with the
PHþ I/R group.
ER stress and mitochondrial damage. Considering the
potential relationship between GSK3b and mitochondrial
VDAC, we evaluated whether changes in GSK3b activity
induced by ER stress could be associated with changes in
mitochondrial VDAC activity. It is well known that ER stress
activates GSK3b (reduces phosphorylated GSK3b
(pGSK3b)) and activates VDAC (increases phosphorylated
VDAC (pVDAC)).10–12,15 Our results indicated that PHþ I/R
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induced activation of GSK3b and VDAC in both liver types
when compared with the sham group. This was evidenced by
the reduced pGSK3b levels and the increased pVDAC levels
observed in both liver types of the PHþ I/R group compared
with the sham group (Figure 8a). In the PBA group, pGSK3b
and pVDAC protein expression levels were similar to those of
the PHþ I/R group. However, TUDCA reduced the activation
GSK3b and VDAC in both liver types when compared with
the PHþ I/R group. This was evidenced by the increased
pGSK3b levels and the reduced pVDAC levels observed in
both liver types of the TUDCA group compared with the
PHþ I/R group. In addition, these results of GSK3b and
VDAC were in accordance with the results for cytochrome
c and caspase 9 (Figure 2b), as only in the TUDCA group but
not in the PBA group, a reduction in cytochrome c and
caspase 9 was observed in both liver types when compared
with the PHþ I/R group. Considering that ERK is a potential
inhibitor of GSK3b10–12,15 and that in our hands, TUDCA
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reduced GSK3b activity in both liver types, we also evaluated
whether the expression of ERK is upregulated by TUDCA. In
the TUDCA group, increased pERK protein expression levels
were observed in both liver types when compared with the
PHþ I/R group (Figure 8b). Total GSK3b, VDAC and ERK
levels were similar in all groups (Figure 8).
Discussion
The data of this study show the activation of all three branches
of UPR: PERK, ATF6, IRE1 and their downstream targets, as
well as the presence of ER stress, evidenced by the induction
of CHOP, GRP78 upregulation and caspase 12 activation in
steatotic and non-steatotic livers under conditions of PHþ I/R.
Our study shows that steatotic livers differed from non-
steatotic livers in their response to UPR and ER stress.
Steatotic livers showed a reduced ability to respond to ER
stress as the activation of two UPR arms, IRE1 and PERK,
was weaker in the presence of steatosis. This could explain
why steatotic livers required lower dose of PBA and TUDCA
than did non-steatotic livers.
Previous studies in experimental models of hepatic I/R
without hepatectomy have indicated that apoptosis and
necrosis were the predominant forms of cell death in lean
and fat rats, respectively.23,26 Different hypotheses, including
decreased ATP production and dysfunction of regulators of
apoptosis, such as Bcl-2, Bcl-xL and Bax have been proposed
to explain the failure of apoptosis in steatotic livers.23,26
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The results of this study may throw some light on this
question. Reduced proapoptotic factors related to ER stress
such as caspase 12, CHOP and JNK3,5,6 were observed in
steatotic livers under conditions of PHþ I/R compared with
non-steatotic livers. In addition, reduced caspase 9 activation
was observed in the presence of steatosis compared with
non-steatotic ones. This may be related to the reduced
activation of the two UPR arms, IRE1 and PERK, which are
responsible for caspase 9 and 12 activation, JNK activation
and CHOP induction.
PBA and TUDCA have been approved for clinical use as
protective agents in various diseases, including urea cycle
disorders, cholestatic liver diseases and cirrhosis.27,28 Con-
sidering our results, targeting the ER with PBA or TUDCA may
provide a novel therapeutic approach in clinical conditions in
which I/R injury and liver regeneration occur, including hepatic
resection under I/R and liver transplantation from reduced
size liver graft. Blocking only one cell death pathway from the
ER may be insufficient to preserve cell survival. PBA and
TUDCA reduced activation of the two UPR arms, IRE1 and
PERK, in both liver types and this in turn, reduced apoptosis,
necrosis and inflammation and improved liver regeneration.
PBA and TUDCA reduced the IRE1 pathway and its down-
stream targets, such as XBP-1(S) and TRAF2. This was
associated with reduced caspase 12 and JNK levels.
However, the reduction in TRAF2 induced by PBA and
TUDCA was associated with increased p38 expression,
suggesting that mechanisms other than TRAF2 could be
responsible for the effects of these ER stress inhibitors
on p38.
The ability of ER stress inhibitors to protect both liver types
under conditions of PHþ I/R is of clinical interest as numerous
strategies that are effective in non-steatotic livers may not be
useful in the presence of steatosis.21 Considering our results,
TUDCA seems to be more effective in reducing hepatic
damage and promoting liver regeneration in both liver types
than PBA. The reduction in caspase release was more evident
in the case of TUDCA. The effect of TUDCA in reducing the
inflammatory response such as neutrophil accumulation,
oxidative stress and proinflammatory mediators including
TNF and IL1 was more evident than in the case of PBA. In
addition, the superior ability of TUDCA to enhance p38
expression compared with PBA may explain at least, partially
the higher beneficial effects of TUDCA on liver regeneration.
The key role of p38 in promoting liver regeneration in both liver
types has been previously demonstrated by our group in the
same experimental model of PHþ I/R.1 Moreover, only
TUDCA protected against mitochondrial damage, which might
also contribute to favor liver regeneration. This conclusion is
based on numerous reports indicating that the mitochondrial
damage induced by I/R is associated with low ATP levels and
increased ROS production. It also stems from other studies
indicating that ATP is necessary for DNA synthesis and that
ROS induce DNA damage and inhibit cell division.21,22,29
ER stress may activate the mitochondrial apoptosis path-
way.9 ER stress induces activation of GSK3b, which in turn
activates mitochondrial VDAC, and apoptosis and necrosis
ensue.12,14,15 Considering our results, ER stress activates
GSK3b and mitochondrial VDAC in both liver types under
conditions of PHþ I/R. This was associated with cytochrome c
release from the mitochondria and caspase 9 activation. PBA
reduced ER stress in both liver types but did not affect the
mitochondrial damage in PHþ I/R. However, TUDCA inhib-
ited ER stress in both liver types and this was associated with
the inhibition of GSK3b, VDAC, cytochrome c release and
caspase 9 activation. Our results indicate that TUDCA
increased ERK in both liver types. This could be responsible
at least partially for the inhibition of GSK3b activity. In fact, the
inactivation of GSK3b by ERK has been described in
cardiomyocytes.12,14,15
In conclusion, ER stress inhibitors, including PBA and
TUDCA could represent effective strategies to reduce hepatic
I/R injury and to improve liver regeneration in steatotic and
non-steatotic livers under conditions of PHþ I/R. The bene-
ficial effects of TUDCA on hepatic I/R injury and liver
regeneration were more evident than those observed for PBA.
Materials and Methods
Experimental animals. Homozygous (obese, Ob) and heterozygous (lean,
Ln) Zucker rats (Iffa-Credo, L’Arbresele, France), aged 16–18 weeks, were used in
the experiments. Ob Zucker rats showed severe macrovesicular and microvesicular
fatty infiltration in hepatocytes (60–70% steatosis). Ln Zucker rats showed no
evidence of steatosis.1 This study complied with European Union regulations
(Directive 86/609 EEC) on animal experiments.
Surgical procedure. A rat model of partial hepatectomy (70%) under 60 min
of ischemia was used. After anesthesia with isofluorane and resection of the left
hepatic lobe, a microvascular clamp was placed for 60 min across the portal triad
supplying the median lobe. Congestion of the bowel was avoided during the
clamping period by preserving the portal flow through the right and caudate lobes. At
the end of ischemia time, the right lobe and caudate lobes were resected, and
reperfusion of the median lobe was achieved by releasing the clamp.1
Experimental groups. The experimental groups were as follow: (1) sham
(n¼ 20, 10 Ln and 10 Ob): hepatic hilar vessels were dissected; (2) PHþ I/R
(n¼ 20, 10 Ln and 10 Ob): partial hepatectomy (70%) under 60 min of ischemia;1
(3) PBA (n¼ 20, 10 Ln and 10 Ob): as in group 2, but treated with PBA (200 and
100 mg/kg in Ln and Ob animals, respectively) before surgery; (4) TUDCA (n¼ 20,
10 Ln and 10 Ob): as in group 2, but treated with TUDCA (100 and 50 mg/kg in
Ln and Ob animals, respectively) before surgery.
Plasma and liver samples corresponding to all experimental groups were
collected at 24 h reperfusion. The range of PBA and TUDCA doses used in this
study is based on previous studies in non-steatotic livers undergoing I/R without
hepatectomy.17,30 Preliminary studies from our group used different doses of PBA
(50, 100, 200 and 400 mg/kg) and TUDCA (25, 50, 100 and 200 mg/kg) for both liver
types and indicated that the doses of PBA and TUDCA chosen for this study were
the most effective in protecting both liver types against hepatic injury and increasing
liver regeneration.
Reverse transcription and real-time PCR. Quantitative real-time
PCR analysis was performed using the Assays-on-Demand TaqMan probe
(Rn 00565250-m1 for GRP78) (Applied Biosystems, Foster City, CA, USA).
The TaqMan gene expression assay was performed according to the
manufacturer’s protocol (Applied Biosystems).
Western blotting. The liver tissue was homogenized as described
previously.31,32 Total liver lysates were then used to quantify GRP78, CHOP,
total PERK and pPERK, total and peIF2a, ATF4, ATF6a, ATF6b, sXBP-1, TRAF2,
cleaved caspase 3, caspase 12, cytochrome c, total and phospho-ERK, total and
phospho-p38 MAPK, total and phospho-GSK3b, total and phospho-JNK, total and
phospho-AKT, as well as total and phospho-VDAC by western blot. Cytosolic
fractions were used to quantify cleaved caspase 9 and cytochrome c by western
blot. Proteins were separated by SDS-PAGE and transferred into polyvinylidene
fluoride membranes. Membranes were immunoblotted with antibodies directed
against GRP78, CHOP, total and pPERK, total and peIF2a, ATF4, ATF6a, ATF6b,
sXBP-1, b-actin (Santa Cruz Biotechnology, Santa Cruz, CA, USA) and TRAF2,
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cleaved caspase 3, cleaved 9 and caspase 12, cytochrome c, total and phospho-
ERK, total and phospho-p38 MAPK, total and phospho-GSK3b, total and phospho-
JNK and total and phospho-AKT (Cell Signalling Technology Inc., Beverly, MA,
USA). The bands were visualized using an enhanced chemiluminescence kit
(Bio-Rad Laboratories, Hercules, CA, USA). The values were obtained by
densitometric scanning and the Quantity One software program (Bio-Rad
Laboratories, Hercules, CA, USA). The scanning values for GRP78, CHOP,
ATF4, ATF6a, ATF6b, sXBP-1, TRAF2, cleaved caspase 3, cleaved caspase 9,
caspase 12 and cytochrome c were divided by the scanning values for b-actin, and
those for phosphorylated PERK, eIF2a, GSK3b, VDAC, ERK, JNK and p38 MAPK
by the total PERK, eIF2a, GSK3b, VDAC, ERK, JNK and p38 MAPK, respectively.
Biochemical determinations. ALT and AST levels, HGF, total and active
TGFb, IL1b, TNFa, MDA, MPO and caspase 3 activity were measured as described
elsewhere.1,21,22,33
PCNA labeling index. The proliferation index of proliferating cell nuclear
antigen (PCNA)-stained biopsy specimens was determined in 30 high-power fields
as reported previously.1 Data are expressed as the percentage of PCNA-stained
hepatocytes per total number of hepatocytes.
Histology and red-oil staining. To appraise the severity of hepatic injury by
optical microscopy, H&E-stained sections were scored on an ordinal scale as
follows: grade 0, minimal or no evidence of injury; grade 1, mild injury consisting of
cytoplasmic vacuolation and focal nuclear pyknosis; grade 2, moderate-to-severe
injury with extensive nuclear pyknosis, cytoplasmic hypereosinophilia and loss of
intercellular borders; and grade 3, severe necrosis with disintegration of hepatic
cords, hemorrhage and neutrophil infiltration.22 Steatosis in liver was evaluated by
red-oil staining on frozen specimens, according to standard procedures.
TUNEL assay. DNA fragmentation was determined using a TUNEL assay in
deparaffinized liver samples as described elsewhere. TUNEL-positive nuclei were
counted.34
Electron microscopy. To appraise the ER and mitochondrial damage by
electron microscopy, liver samples were processed as reported previously and
stained sections were viewed under an H 600-AB Hitachi electron microscope
(Hitachi, Tokyo, Japan).35,36 In all, 20 hepatocytes from each specimen were
examined. Damage to the mitochondria and ER (rough and smooth) was scored as
follows. For the mitochondria: grade 0, normal; grade 1, prominent cristae; grade 2
swelling; grade 3, collection and amorphous material. For ER: grade 0, normal;
grade 1, dilatation; grade 2, irregular lamellar organization and vacuolization, grade
3, presence of focal breaks.
Statistics. Data are expressed as means±S.E. and were compared statistically
by variance analysis, followed by the Student–Newman–Keuls test. Po0.05 was
considered significant.
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